|
Unique Study ID
|
AA-AA-000-0000
|
|
Protocol title
|
Protocol Title
|
|
Sites (Enrolled / Planned)
|
176 / 190
|
|
Participants (Enrolled / Planned)
|
1301 / 1300
|
|
Date that snapshot was created
|
2018-01-01
|
|
Study Status
|
Active
|
|
Product
|
Product
|
|
Phase
|
P3
|
|
Therapeutic Area
|
Therapeutic Area
|
|
Indication
|
Protocol Indication
|
|
First-patient first visit date
|
2003-01-01
|
|
Estimated first-patient first visit date from GILDA
|
2003-01-01
|
|
Last-patient first visit date
|
2020-06-01
|
|
Estimated last-patient first visit date from GILDA
|
2020-06-01
|
|
Last-patient last visit date
|
2021-06-01
|
|
Estimated last-patient last visit date from GILDA
|
2021-06-01
|
|
Average snapshot interval
|
-730.5 days
|
|
Median snapshot interval
|
-730.5 days
|